Correct answer: D — Rifampin, isoniazid, pyrazinamide, and ethambutol
- ABedaquiline, linezolid, and pretomanid
- BRifampin and isoniazid
- CIsoniazid monotherapy
- DRifampin, isoniazid, pyrazinamide, and ethambutol✓
Why Rifampin, isoniazid, pyrazinamide, and ethambutol is correct
- Active drug-susceptible pulmonary tuberculosis requires the standard first-line regimen: a 2-month intensive phase of rifampin, isoniazid, pyrazinamide, and ethambutol (RIPE), followed by a 4-month continuation phase of rifampin and isoniazid.
- Four drugs are used initially to prevent emergence of resistance and rapidly reduce bacillary load.
Why the others are wrong
- Bedaquiline, linezolid, and pretomanid — the BPaL regimen is reserved for multidrug- or extensively drug-resistant TB, not drug-susceptible disease (wrong-resistance-tier).
- Rifampin and isoniazid — this two-drug combination is the continuation phase used after the intensive phase, inadequate as initial therapy (right-drugs-wrong-phase).
- Isoniazid monotherapy — the regimen for latent TB infection without active disease; using it here would select for resistance (confused-with latent TB).
Additional high-yield points
- Directly observed therapy is recommended to ensure adherence.